A study evaluating safety and efficacy of entecavir and tenofovir in adult caucasians with chronic hepatitis B in real world setting.

Next Previous
Trial Profile

A study evaluating safety and efficacy of entecavir and tenofovir in adult caucasians with chronic hepatitis B in real world setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jan 2017

At a glance

  • Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use

    • Most Recent Events

    • 19 Jan 2017 New trial record
    • 11 Jan 2017 Results published in the Digestive Diseases and Sciences
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top